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A critical aspect of viral replication is the assembly of virus particles, which are subsequently
released as progeny virus. While a great deal of attention has been focused on better
understanding this phase of the viral life cycle, many aspects of the molecular details
remain poorly understood. This is certainly true for retroviruses, including that of the
human immunodeﬁciency virus type 1 (HIV-1; a lentivirus) as well as for human T-cell
leukemia virus type 1 (HTLV-1; a deltaretrovirus). This review discusses the retroviral Gag
protein and its interactions with itself, the plasma membrane and the role of lipids in
targeting Gag to virus assembly sites. Recent progress using sophisticated biophysical
approaches to investigate – in a comparative manner – retroviral Gag–Gag and Gag–
membrane interactions are discussed. Differences among retroviruses in Gag–Gag and
Gag–membrane interactions imply dissimilar molecular aspects of the viral assembly
pathway, including the interactions of Gag with lipids at the membrane.
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The assembly of virus particles is a key aspect of viral repli-
cation that is still poorly understood at the molecular level.
Retroviral assembly has been extensively investigated, though
detailed information is lacking for many aspects of the pro-
cess. This is true for human immunodeﬁciency virus type
1 (HIV-1), and particularly true for human T-cell leukemia
virus type 1 (HTLV-1). In this review, we review the retro-
viral Gag protein, its translocation to the plasma membrane
(PM), as well as Gag–Gag and Gag–PM interactions. We then
highlight recent progress made using sophisticated biophysi-
cal approaches to investigate Gag–Gag and Gag–PM interac-
tions, which represent key early events in the virus assem-
bly pathway, including that of interacting with lipids at the
PM.
THE Gag POLYPROTEIN
Gag is the primary retroviral structural protein responsible for
orchestrating the majority of steps in viral assembly. Most
of these assembly steps occur via interactions with three Gag
subdomains – matrix (MA), capsid (CA), and nucleocapsid
(NC; Figure 1). These three regions have a low level of
sequence conservation among the different retroviral genera,
which belies the observed high level of structural conserva-
tion. Outside of these three domains, Gag proteins can vary
widely. For example, HIV-1 Gag additionally codes for a
C-terminal p6 protein as well as two spacer proteins, SP1
and SP2, which demarcate the CA–NC and NC–p6 junctions,
but HTLV-1 contains no additional sequences outside of MA,
CA, and NC (Oroszlan and Copeland, 1985; Henderson et al.,
1992).
The Gag subdomains are structurally discrete but have func-
tionally overlapping roles in the viral assembly process. The
N-terminus of Gag begins with MA, which contains key residues
responsible for the recruitment of Gag to the PMvia anN-terminal
myristoyl moiety and a highly basic region (Bryant and Rat-
ner, 1990; Zhou et al., 1994; Ono et al., 2000; Stansell et al.,
2007; Hamard-Peron et al., 2010). CA is divided into two struc-
turally distinct domains – the N-terminal domain (NTD) and
C-terminal domain (CTD) – and contains the majority of the
residues responsible for Gag–Gag interactions. While the pri-
mary amino acids for HIV-1 Gag oligomerization are located
in the CA CTD (Dorfman et al., 1994; Gamble et al., 1997;
Alfadhli et al., 2005; Dalton et al., 2007; Datta et al., 2007),
there are additional residues located throughout CA, NC, and
SP1 that are responsible for laterally stabilizing Gag–Gag inter-
actions (Krausslich et al., 1995; von Schwedler et al., 2003; Li
et al., 2007). Functionally distinct from the CTD, in HIV-
1 the CA NTD is not necessary for viral assembly (Borsetti
et al., 1998; Accola et al., 2000). Finally, NC possesses two
zinc ﬁnger domains along with several key amino acids that
function to bind and package viral RNA into particles (Gore-
lick et al., 1988; Cimarelli et al., 2000; Muriaux et al., 2004).
It is important to note that the functions of these domains
are not exclusive, and there is much overlap. For example,
HIV-1 NC has recently been implicated in facilitating the
budding process, which was believed to be driven solely by
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FIGURE 1 | Gag and retrovirus particle assembly. A cartoon depiction is
shown in cross section of the assembly of a prototypic retrovirus particle,
emphasizing the oligomerization of Gag along the inner leaﬂet of the plasma
membrane, incorporation of two copies of the viral RNA, the budding of
immature virus particles, and the conversion of the immature virus particle to
mature infectious virus particle that is catalyzed by the viral-encoded
protease. Gag is shown as being composed of the matrix domain (red circle),
the capsid domain (blue oval), and the nucleocapsid domain (purple circle).
Two copies of the viral RNA (two orange lines inside the viral particle) are
shown packaged into the virus particle.
motifs within the p6 domain (Dussupt et al., 2011; Bello et al.,
2012).
Once a cell has been infected by a retrovirus, full-length Gag
polyproteins assemble to form immature virions. The reported
numbers of Gag incorporated in each particle varies greatly from
∼750–5000 (Yeager et al., 1998;Vogt and Simon,1999; Briggs et al.,
2004; Chen et al., 2009). It is theorized that the preparation of the
particles can affect this number as well as the genus of retrovirus.
Upon the assembly of these Gag proteins into a lattice shell, the
viral protease will cleave the Gag polyprotein into its respective
domains to form a mature virus. This cleavage event changes the
virus morphology, yielding a CA core, which is conical in the case
of HIV-1 (Ganser et al., 1999; Briggs and Krausslich, 2011). In
addition to the change in morphology, the individual Gag domain
proteins no longer exhibit the same roles as the full-length Gag
polyprotein.
Gag TRAFFICKING TO THE PLASMA MEMBRANE
Previously, retroviral research posited that Gag proteins traf-
ﬁcked to endosomal compartments and assembled there. This
model was based on studies that found Gag in intracellu-
lar endosomal compartments (Raposo et al., 2002; Nydegger
et al., 2003; Pelchen-Matthews et al., 2003) as well as studies
that found virions associated with the mannose receptor CD63
(Nguyen and Hildreth, 2003; Ono et al., 2004; Gousset et al.,
2008). Over the past decade, this idea has been challenged by stud-
ies showing that the vacuolar structures bearing retroviral virions
were actually invaginations of the PM (Welsch et al., 2007; Finzi
et al., 2013). Additionally, it was found that HIV-1 Gag is only
found in endosomes at late time points and preventing endosomal
function with drugs does not inhibit the release of viral parti-
cles (Jouvenet et al., 2006; Finzi et al., 2007). Based upon these
and other studies, it is generally agreed that the productive site of
retroviral particle assembly is the PM.
Before particle assembly can occur at the PM, Gag must trafﬁc
fromthe site of synthesis through the cytoplasm.While this process
is not well-understood, it is increasingly thought that Gag must
interact with a large amount of host cell machinery, including
microtubule networks, motor proteins, and vacuolar transport
complexes.
Microtubules are highly dynamic structures that make up
the cytoskeleton of the cell. They serve as the road-like struc-
tures that motor proteins such as kinesins use to trafﬁc cellu-
lar cargo to various cytoplasmic locations (Vale, 2003). It has
been shown that HIV-1 Gag interacts with kinesin superfam-
ily member KIF4, a protein that trafﬁcs cellular cargo from the
perinucleolar region to the membrane (Hirokawa and Noda,
2008). Downregulating KIF4 not only slows Gag trafﬁcking
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and reduces particle production but also seemingly increases
intracellular Gag degradation, indicating that KIF4 has some
sort of stabilizing action. Additionally, suppressor of cytokine
signaling 1 (SOCS1) has been shown to colocalize with Gag
along the cytoskeleton and promote microtubule stability (Nishi
et al., 2009). These studies would indicate that Gag binds
to host cell proteins to stabilize its transport via cytoskeletal
networks.
The idea that Gag utilizes the microtubule network to directly
trafﬁc to the PM is not without controversy (Naghavi and Goff,
2007). Other studies have shown that kinesin family members
that direct membranous organelles such as endosomes and lyso-
somes to the PM are involved in HIV-1 replication (Brass et al.,
2008; Konig et al., 2008; Zhou et al., 2008). Studies have yet to rec-
oncile these different pathways of Gag transport. It is likely that
there are multiple trafﬁcking pathways that lead to Gag expres-
sion at the PM, but further analyses need to be done to clarify the
mechanisms.
DETERMINANTS OF Gag–Gag INTERACTIONS
The formation of Gag–Gag oligomers appears to be a com-
plex and multifactorial process involving several Gag domains,
host proteins, and environmental factors. Examples of important
host proteins include the molecular motors and microtubule net-
works mentioned above, which can concentrate Gag in particular
locations of the cell (Naghavi and Goff, 2007). Gag concentra-
tion levels as well as subcellular location of Gag are some of
the important environmental factors that can contribute to Gag
oligomerization.
It is known that CA is the primary region involved in oligomer-
ization (Gamble et al., 1997). In HIV-1, it has been shown that
mutations speciﬁcally in the CA CTD affect Gag–Gag interactions
and severely impede viral particle production (von Schwedler
et al., 2003). Based on studies using chimeric Gag molecules with
differentCAdomains, it appears that this is the case for other retro-
viruses as well (Ako-Adjei et al., 2005). In HTLV-1, the CA NTD
is required in addition to the CTD to form Gag–Gag interactions
(Rayne et al., 2001).
While CA is typically thought to be the primary site of Gag–Gag
interactions, other Gag domains are necessary for stabilizing these
interactions. NC has been shown to be an important factor in the
formation of Gag–Gag interactions, likely due to its RNA-binding
capacities. However, it has also been shown that the HIV-1 MA
NTD is capable of binding to the RNA through an electrostatic
interaction (Purohit et al., 2001). RNA may serve as a binding
platform for Gag assembly, as it may promote Gag oligomeriza-
tion and expose domains necessary for interactions with the PM
(Figures 2A,B; Khorchid et al., 2002; Hogue et al., 2009; Rein et al.,
2011).
Myristoylation appears to be another requirement for Gag–
Gag multimerization, at least in the case of HIV-1 (Li
et al., 2007; O’Carroll et al., 2012). Fluorescence resonance
energy transfer (FRET) studies found that without a myris-
tic acid moiety, there was a signiﬁcant decrease in Gag–
Gag interactions. The simplest explanation for this phe-
nomenon is that myristoylation concentrates Gag molecules at
the PM, bringing the CA domains into contact and facilitating
oligomerization.
The requirement for the CA interface, nucleic acid scaffold-
ing, and myristic moiety have repeatedly been conﬁrmed (Li
et al., 2007; O’Carroll et al., 2012, 2013). It appears that this
“functional redundancy” allows for some give in the ability of
HIV-1 to assemble – only two of the three components are
necessary for VLP production – but when more than one func-
tion is ablated, no particles can be produced (O’Carroll et al.,
2012).
FIGURE 2 | Schematic representation of HTLV-1 and HIV-1 Gag–
membrane association. (A) HTLV-1 Gag associates with the plasma
membrane (PM) as a monomer and is found in the PM at nM concentrations.
HTLV-1 Gag is shown as recruiting viral RNA after its association with the
inner leaﬂet of the PM (though monomeric Gag may recruit the viral RNA in
the cytoplasm and are transported together to the PM). (B) Concentration-
dependent HIV-1 Gag dimerization and translocation to the PM. HIV-1 Gag
must reach a critical cytoplasmic concentration (∼0.5 μM) in order for
Gag–Gag dimers to form and subsequent Gag–membrane association
to occur. The myristoyl moiety of the HIV-1 Gag is exposed, allowing for
association with the PM of Gag dimers (including Gag dimers associated with
dimeric viral RNA). Both HIV-1 Gag N- and CTD interact with the inner leaﬂet
of the PM and to NA, but is not until HIV-1 Gag interacts with the PM, other
HIV-1 Gag molecules, and to NA that the protein becomes extended. (C)
Expanded view of lipid raft that HIV-1 Gag associates with at the PM.
Shown are three key constituents of lipid rafts: cholesterol (yellow),
phosphatidylserine (PS; blue), and phosphatidylinositol 4,5-bisphosphate
[PI(4,5)P2; red].
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Gag OLIGOMERIZATION
Eventually, Gag must form higher order oligomers (e.g., dimers,
trimers) in order to form the lattice structure seen in imma-
ture virions and virus-like particles. It is unlikely that these
large-scale interactions form in the cytosol, as Gag is translated
as a soluble protein. Gag–Gag interactions have been primar-
ily studied using HIV-1 as a model system. This system has
been thought to be useful due to the structural similarities
between retroviruses, speciﬁcally the MA domain. Initial stud-
ies used crosslinking to show that HIV-1 Gag mainly exists as a
dimer in the cytoplasm and does not form trimers or hexam-
ers until it reaches the PM (Kutluay and Bieniasz, 2010). This
observation was recently conﬁrmed using dual-color z-scan ﬂu-
orescence ﬂuctuation spectroscopy (dczFFS), which quantiﬁes
ﬂuorescent proteins inside of living cells (Fogarty et al., 2011,
2013).
It has typically been thought that other retroviruses, such as
HTLV-1, trafﬁcked to and assembled at the PM in a similar fash-
ion to that of HIV-1. Using dcz-FFS together with total internal
reﬂection ﬂuorescence and conventional, epi-illumination imag-
ing, it was recently reported that HIV-1 requires micromolar
concentrations of Gag in order for it to target and associate
with the PM (Figure 2B), while HTLV-1 only requires nanomo-
lar concentrations of Gag to become associated with the PM
(Figure 2A). These results correlate with previous observations
that HTLV-1 Gag–Gag interactions were absent in the cytoplasm
(Fogarty et al., 2011). This data also supports the hypothe-
sis that HTLV-1 reaches the PM as a monomer where it then
forms higher order oligomers (Figure 2A), which is in con-
trast to HIV-1 Gag–Gag interactions, which trafﬁcs as lower
order oligomers in the cytoplasm prior to targeting the PM
(Figure 2B; Lindwasser and Resh, 2001; Perez-Caballero et al.,
2004). Therefore, HTLV-1 Gag monomers must translocate to
the same area at the inner leaﬂet of the PM to form Gag–Gag
oligomers (Figure 2A).
The facts that HTLV-1 NC is a bad chaperone (Qualley et al.,
2010) and that HTLV-1 Gag–membrane interaction is indepen-
dent of viral RNA binding (Inlora et al., 2011), taken together
with the ﬁnding that HTLV-1 Gag targets the PM at low cyto-
plasmic concentrations (Fogarty et al., 2013), suggest that the viral
RNA interacts with Gag at the PM, acting as a scaffold for Gag–
Gag interactions (Figure 2A). However, it is possible that HTLV-1
monomers interact and trafﬁc the viral RNA to the PM. In the case
of HIV-1 Gag, it has been suggested that only a few Gag molecules
are needed to recruit the viral RNA to the cytoplasm, which play
an important role in initiating the assembly of HIV-1 virions at
the PM (Figure 2B; Jouvenet et al., 2009). This indicates that dif-
ferent retroviruses may have different determinants of Gag–Gag
interactions and Gag trafﬁcking pathways, despite similarities in
viral particle morphology.
Gag–MEMBRANE INTERACTIONS
In order for Gag molecules to initiate particle assembly, it must
recognize a site of assembly at the PM where it oligomerizes
into higher-order multimers. It has been shown that Gag targets
and assembles at speciﬁc PM microdomains known as lipid rafts,
which are dense, ordered groups of tightly packed saturated lipids
stabilized by cholesterol (Figure 2C). The molecular composition
of these lipid rafts is different than that of the surrounding mem-
brane (Lingwood et al., 2009; Ono, 2009; Sonnino and Prinetti,
2013).
MA is responsible for the binding of Gag to the inner leaﬂet of
the PM,which is mediated by the MA NTD that contains multiple
membrane binding signals necessary for membrane interactions.
A hydrophobic myristic acid moiety found in MA of most retro-
viruses, such as HIV-1 and HTLV-1, plays an important role
in targeting and inserting Gag to the inner leaﬂet of the PM
(Ootsuyama et al., 1985; Zhou and Resh, 1996; Resh, 1999, 2004;
Tang et al., 2004). MA also contains a highly basic region, mostly
arginines and lysines, that interacts electrostatically with the inner
leaﬂet of the PM. Furthermore, it has been shown that HIV-1 Gag
is ﬂexible and can adopt a closed conformation, which brings
the MA and NC terminal domains in close proximity, allow-
ing these to interact with the anionic inner leaﬂet of the PM
(Figure 2B; Datta et al., 2011). The inner leaﬂet of the PM is
rich in acidic phospholipids, such as phosphatidylserine (PS) and
acidic phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2], which
is important for efﬁcient membrane binding and targeting to
the PM (Figure 2C; Murray et al., 2005; Chukkapalli et al.,
2008).
CHARACTERISTICS ALONG THE INNER LEAFLET OF THE
PLASMA MEMBRANE THAT ARE SITE OF Gag ASSEMBLY
The PM is composed of different transmembrane proteins and a
wide variety of lipids. These include cholesterol andmultiple phos-
pholipids such as phosphatidylinositol phosphates (PIPs), phos-
phatidyl glycerol (PG), and PS; however, the most abundant lipids
are phosphatidylcholine (PC) and phosphatidylethanolamine
(PE). The inner leaﬂet of the PM is mostly composed of PE, PC,
PS, and PI(4,5)P2, which makes it acidic and better suited for
MA to interact with the PM (van Meer et al., 2008; Chukkapalli
and Ono, 2011). HIV-1 Gag uses each one of these lipids as a
signal to recognize the PM. However, as one of the main lipids
in the inner leaﬂet, it has been suggested that HIV-1 Gag pri-
marily interacts with PI(4,5)P2 which promotes the HIV-1 Gag
to preferentially target the PM (Ono et al., 2004). Further stud-
ies have contradicted these ﬁndings and suggest that PI(4,5)P2
is not the most important site-speciﬁc acidic signal in the PM
for HIV-1 Gag, HTLV-1 and other retroviral Gag proteins (e.g.,
RSV Gag) that do not have a PI(4,5)P2 binding signal, but rather
can strongly interact with other acidic phospholipids (Chan et al.,
2011; Inlora et al., 2011). However, contradictory results show that
RSV Gag does interact with PI(4,5)P2 at the PM (Nadaraia-Hoke
et al., 2013). Furthermore, HIV-1 can differentiate membranes
with multiple compositions of fatty acids and cholesterol (Dick
et al., 2012).
Gag MOVEMENT AND TRAFFICKING ALONG THE INNER
LEAFLET
A new assembly model for HIV-1 suggests that the viral genome
is recruited by Gag and then directed and anchored to the
PM (Jouvenet et al., 2009). In the latter location, the RNA–Gag
complex functions as a scaffold to form large Gag oligomers
by recruiting other Gag molecules (Figures 2A,B). The lateral
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movement of the viral RNA in the PM and the progressive accu-
mulation of Gag molecules over time, suggest that after the
RNA–Gag complex attaches to the PM, it moves in the PM
plane to recruit more Gag molecules. Furthermore, it has been
shown that HIV-1 Gag translocate from internal compartments
towards virological synapses, which are the contact sites that
allow the virus to be transferred, between infected macrophages
and uninfected T cells (Gousset et al., 2008). Therefore, it is
possible that the Gag anchored to the PM can also trafﬁc to
these virological synapses. Further studies need to be done to
fully understand Gag movement along the infer leaﬂet of the
PM.
CONCLUDING REMARKS
Recent observations have demonstrated differences in the form
and concentration of Gag that is associated with translocation to
the PM.While HIV-1 Gag dimers are the primary form of Gag that
is thought to translocate to the PM at μM cytoplasmic concentra-
tions (i.e., concentration dependent translocation), HTLV-1 Gag
has been found to translocate to the PM as a monomer at nM
cytoplasmic concentrations. These observations indicate that fun-
damental differences may exist in the association of different Gag
proteins with the PM, including interactions with lipids. Further-
more, such differences suggest that the movement of Gag along
the inner leaﬂet of the PM may also be distinct among differ-
ent retroviruses. Taken together, these observations argue for the
importance of comparative studies of retroviruses in order to pro-
vide the greatest insights into the diversity of strategies associated
with the virus assembly pathway.
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